Jung-Woo Choi Selected Research

Jung-Woo Choi Research Topics

Disease

17	Neoplasms (Cancer) 04/2022 - 07/2006
4	Stomach Neoplasms (Stomach Cancer) 08/2021 - 09/2017
4	Renal Cell Carcinoma (Grawitz Tumor) 04/2020 - 10/2011
4	Lymphatic Metastasis 10/2018 - 08/2011
3	Carcinogenesis 01/2022 - 09/2014
3	Neoplasm Metastasis (Metastasis) 08/2021 - 10/2011
3	Breast Neoplasms (Breast Cancer) 10/2018 - 08/2011
3	Carcinoma (Carcinomatosis) 07/2014 - 11/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2022 - 02/2007
2	Foreign Bodies (Foreign Body) 02/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 09/2011
2	Aneuploidy (Aneuploid) 09/2014 - 11/2013
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2013 - 02/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2022
1	Squamous Intraepithelial Lesions 04/2022
1	Fibrosis (Cirrhosis) 02/2022
1	Lymphoma (Lymphomas) 01/2022
1	Fecal Incontinence 01/2022
1	Vascular Diseases (Vascular Disease) 01/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022
1	Non-Muscle Invasive Bladder Neoplasms 01/2021
1	Hypoxia (Hypoxemia) 01/2015
1	Lymphadenopathy 01/2014
1	Neurofibroma 01/2014
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 12/2013
1	Hematologic Neoplasms (Hematological Malignancy) 02/2013
1	Hearing Loss (Hearing Impairment) 01/2013
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2012
1	Hodgkin Disease (Hodgkin's Disease) 04/2012
1	Cysts 02/2012
1	Colonic Neoplasms (Colon Cancer) 09/2011
1	Melanoma (Melanoma, Malignant) 02/2007
1	Basal Cell Carcinoma (Rodent Ulcer) 02/2007
1	Keratoacanthoma 02/2007
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2006
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2006
1	Epstein-Barr Virus Infections 07/2006

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 02/2022 - 08/2011
3	Fatty Acid Transport Proteins (Fatty Acid Transport Protein)IBA 04/2022 - 01/2019
3	Fatty Acids (Saturated Fatty Acids)IBA 04/2022 - 01/2019
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 07/2014
3	TubulinIBA 04/2014 - 02/2007
3	Tissue Inhibitor of Metalloproteinase-1IBA 09/2011 - 07/2006
2	RNA (Ribonucleic Acid)IBA 08/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2020 - 07/2006
2	SymportersIBA 01/2015 - 07/2014
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2013 - 10/2011
2	Plasminogen Activator Inhibitor 1IBA 01/2013 - 10/2011
1	SiliconesIBA 02/2022
1	oxidized low density lipoproteinIBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	LactatesIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	PolymersIBA 01/2022
1	Aurora Kinase AIBA 08/2021
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2021
1	Ligases (Synthetase)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Cell-Free Nucleic AcidsIBA 10/2018
1	Circulating Tumor DNAIBA 10/2018
1	B7-H1 AntigenIBA 12/2017
1	Immune Checkpoint InhibitorsIBA 12/2017
1	Protons (Proton)IBA 07/2014
1	Coffee FDA Link 01/2014
1	Imatinib Mesylate (Gleevec)FDA Link 12/2013
1	milatuzumabIBA 02/2013
1	Plasminogen InactivatorsIBA 01/2013
1	PrionsIBA 11/2012
1	MucinsIBA 02/2012
1	Glycoproteins (Glycoprotein)IBA 08/2011
1	Matrix Metalloproteinases (MMPs)IBA 08/2011
1	TESIBA 02/2007

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2021
1	Eyeglasses (Spectacles) 01/2013
1	Drug Therapy (Chemotherapy) 04/2012